Elizabeth Holmes loses final bid to stay out of prison in fraud conviction

Theranos Inc. founder will soon have to report to prison to begin her 11 1/4-year sentence after she was convicted by a jury last year of defrauding investors

Photo: Bloomberg
Photo: Bloomberg
Bloomberg
1 min read Last Updated : May 17 2023 | 8:25 AM IST
By Joel Rosenblatt

Elizabeth Holmes lost her final request to remain free on bail while she appeals her fraud conviction.
 
The ruling Tuesday by the US Court of Appeals in San Francisco means the Theranos Inc. founder will soon have to report to prison to begin her 11 1/4-year sentence after she was convicted by a jury last year of defrauding investors in the blood-testing startup.

Holmes had won a brief pause delaying the start of her prison term while the appeals court considered her request. The appeals panel upheld the lower-court judge who presided over Holmes’s trial and denied her request for bail. She can still pursue her appeal of her conviction, but must do so from prison.

Former Theranos President Ramesh “Sunny” Balwani’s similar request was also denied. He reported to prison last month to begin his 13-year sentence.

The case is USA v. Holmes, 18-cr-00258, US District Court, Northern District of California (San Jose).
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :USATheranos

First Published: May 17 2023 | 8:25 AM IST

Next Story